Takeaways from Our Conversation with Insuring Cannabis Pro About His Son’s CBD TrialPosted by On


Erich Schutz has been a cannabis insurance specialist since around the time it first became legal, dropping into a competitive business with acumen, knowledge and passion. He even adopted a “cannabis ninja” nickname.

Schutz, vice president and cannabis practice leader at Jencap Specialty Insurance Services, is also a father who has been going through some significant challenges.

His son, Wallace David, was diagnosed with Fragile X syndrome, a genetic disorder caused by changes in a gene called Fragile X Messenger Ribonucleoprotein 1. FMR1 usually makes a protein called FMRP that is needed for brain development. People who have FXS do not make this protein.

Males who have FXS usually have some degree of intellectual disability that can range from mild to severe, according to the Centers for Disease Control. Symptoms include: developmental delays; learning disabilities, and social and behavior problems.

Erich Schutz, vice president and cannabis practice leader at Jencap Specialty Insurance Services, applies a topical trial CBD drug to his son to help alleviate some of his Fragile X symptoms.

The 4-year-old’s difficulties included anxiety, pain, and sleeping was big problem – and that meant sleeping was a big problem for Erich and his wife Lexie.

What was available to help Wally were established pharmaceuticals that did little to relieve some of the symptoms that posed such a challenge to the daily lives of Erich and his family – namely sleep and anxiety…

Original Author Link click here to read complete story..

News

cbdErich SchutzInsuring cannabisJencap Specialty Insurance Services

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.